I.v. immunoglobulins ( DrugBank: - )
1 disease
告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
151 | ラスムッセン脳炎 | 1 |
151. ラスムッセン脳炎
臨床試験数 : 1 / 薬物数 : 2 - (DrugBank : 1) / 標的遺伝子数 : 5 - 標的パスウェイ数 : 33
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT00545493 (ClinicalTrials.gov) | November 2002 | 16/10/2007 | Efficacy of Tacrolimus and I.V.-Immunoglobulins in Rasmussen Encephalitis | Efficacy of Tacrolimus and i.v.-Immunoglobulins in Rasmussen Encephalitis With Start of Treatment in the Acute Disease Stage. Prospective, Randomised, Open Parallel Group Study | Rasmussen Encephalitis | Drug: Tacrolimus;Drug: i.v. immunoglobulins | University Hospital, Bonn | Octapharma;Astellas Pharma GmbH | Active, not recruiting | N/A | N/A | Both | 16 | Phase 2/Phase 3 | Germany |